Medical imaging and nuclear medicine are fundamental techniques used in today’s health care for diagnosing and treating diseases, with a measurable impact on saving patients’ lives. However, the globa ...
Traumatic spinal cord injury (SCI) is a serious neurologic disorder that can result in long-term motor and sensory ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
Artificial intelligence–generated content (AIGC) has shown remarkable performance in nuclear medicine imaging (NMI), offering cost-effective software solutions for tasks such as image enhancement, ...
Dr. David Nathanson is a professor of molecular and medical pharmacology at UCLA. He received his Ph.D. in molecular and medical pharmacology at UCLA under Dr. Paul Mischel, where he discovered that ...
The internal dosimetry schema of the Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine has provided a broad framework for assessment of the absorbed dose to whole ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Since its publication in 1990 (1), the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study has played a central role in informing algorithms used to diagnose pulmonary embolism ...
Journal of Nuclear Medicine February 2026, jnumed.125.271410; DOI: https://doi.org/10.2967/jnumed.125.271410 ...
PET/CT imaging of cancer with combined PET and CT scanners has become a standard component of diagnosis and staging in oncology (1,2). The glucose analog 18 F-FDG has been shown to concentrate in ...
Journal of Nuclear Medicine January 2026, jnumed.125.271020; DOI: https://doi.org/10.2967/jnumed.125.271020 ...
Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89 Sr trials, this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results